Reflex Sympathetic Dystrophy Clinical Presentation

  • Author: Don R Revis Jr, MD; Chief Editor: Herbert S Diamond, MD   more...
 
Updated: Jan 19, 2012
 

History

The 3 clinical stages of reflex sympathetic dystrophy (RSD) are acute, subacute, and chronic. The acute form lasts approximately 3 months. Pain, often burning in nature, is one of the first symptoms that initially limits function. Swelling, redness with vasomotor instability that worsens with dependency, hyperhidrosis, and coolness to the touch are common physical findings. Demineralization of the underlying bony skeleton begins because of disuse.

If the process is not arrested or reversed in the acute phase, the condition may progress to the subacute stage, which can last for up to 9 months. The patient develops persistent severe pain in the extremity and fixed edema that would have been reversible with elevation during the acute phase. The redness of the acute stage gives way to cyanosis or pallor and hyperhidrosis to dry skin. Loss of function progresses, both because of increased pain and fibrosis of the joints caused by chronic inflammation. In the hand, this leads to flexion deformity of the fingers. The skin and subcutaneous tissues begin to atrophy. Demineralization of the underlying bony skeleton becomes pronounced.

If the process continues, the chronic phase may develop approximately 1 year after disease onset. This stage may last for many years or can be permanent. Pain is more variable during this period. It may continue undiminished or abate. Edema tends to subside over time, leaving fibrosis around the involved joints. The skin is dry, pale, cool, and shiny. Flexion and extension creases are absent. Loss of function and stiffness are marked, and osteoporosis is extreme. In the upper extremity, this can manifest as a frozen shoulder and claw hand.

A thorough general history is strongly suggested. Maintaining a high index of suspicion is important because proper treatment requires rapid diagnosis and prompt therapy.

  • RSD commonly involves only one extremity. It is bilateral in approximately 25% of cases but is usually more prominent on one side.
  • Pain
    • Usually constant and disproportionate to the precipitant injury
    • May be exacerbated by ambient factors such as loud noises and emotional factors (eg, stress, light touch, active motion, passive motion)
    • May be described as burning, cutting, searing, pressure, or tearing
    • Usually begins locally but may progress to involve the entire extremity
  • Possible evidence of prior increased sympathetic activity
    • Hyperhidrosis
    • Cold hands
    • Fainting
  • Prior trauma, which may be trivial or significant (eg, Colles fracture), with or without diagnosable nerve injury
  • Prior surgery
  • Recent limb immobilization due to hemiplegic stroke, myocardial infarction
  • Systemic disease such as diabetes
Next

Physical

Perform a thorough physical examination followed by a focused examination of the involved extremity. Patients with RSD may present with suggestive physical findings that point to a presumptive diagnosis.

  • Edema
    • Edema is the most consistent physical finding and is always disproportionate to the severity of the precipitant injury or event.
    • Pain, swelling, and color change may be more prominent with dependency in the early stages.
    • Edema worsens rather than improves and extends beyond the region of initial concern.
    • It evolves into a brawny, nonpitting edema that may progress to an intense fibrosis in all the joints of the extremity.
  • Stiffness is more severe than expected and may be very distressing to the patient.
  • Discoloration
    • Varies depending on the stage of disease
    • May be dusky, cyanotic, pale, or red and may eventually lead to skin hypopigmentation
    • Begins as redness over the metacarpophalangeal (MCP) or proximal interphalangeal (PIP) joint flexion creases early in the disease and progresses as a streak across the palm
  • Abnormal skin moisture
    • Hyperhidrosis (early)
    • Dry skin (late)
  • Tenderness is initially localized but may progress to generalized tenderness. Exquisite tenderness, both periarticular and interarticular, is often present. Patients may exhibit allodynia (ie, pain with nonnoxious stimuli) and hyperpathia (ie, persistent pain after light pressure).
  • Atrophy of the skin and subcutaneous fat pads
  • Fibrosis of the palmar fascia
  • Absence of extensor and flexor creases over joints
  • Frozen shoulder, flexion deformities of the fingers, claw hand
Previous
Next

Causes

RSD is usually posttraumatic or postsurgical; however, it can occur in a previously healthy extremity with no known trigger.

  • Trauma
    • Penetrating wounds
      • Lacerations
      • Abrasions
      • Venipuncture
      • Intramuscular injection of medication or illicit drugs
      • Gunshot wounds
    • Crush injuries and blunt trauma
    • Neck or shoulder injuries
    • Acute traumatic carpal tunnel syndrome
    • Chest trauma
    • Sprain, fracture, or dislocation
  • Postsurgery
    • Carpal tunnel release
    • Dental extractions
    • Cervical rib resection
    • Fracture repair (Colles fracture)
    • Postarthroscopy
  • Local disease
    • Nerve compression syndromes
    • Arthritis
    • Tissue ischemia
    • Stenosing tenosynovitis
  • Systemic disease
    • Myocardial infarction
    • Stroke
    • Pancoast tumor
    • Pancreatic cancer
    • Herpes zoster
Previous
 
 
Contributor Information and Disclosures
Author

Don R Revis Jr, MD  Consulting Staff, Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Florida College of Medicine

Don R Revis Jr, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Society for Aesthetic Plastic Surgery, and American Society of Plastic Surgeons

Disclosure: Nothing to disclose.

Coauthor(s)

Elliot Goldberg, MD  Dean of the Western Pennsylvania Clinical Campus, Professor, Department of Medicine, Temple University School of Medicine

Elliot Goldberg, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, and American College of Rheumatology

Disclosure: Nothing to disclose.

Specialty Editor Board

Robert E Wolf, MD, PhD  Professor Emeritus, Department of Medicine, Louisiana State University School of Medicine in Shreveport; Chief, Rheumatology Section, Medical Service, Overton Brooks Veterans Affairs Medical Center

Robert E Wolf, MD, PhD is a member of the following medical societies: American College of Rheumatology, Arthritis Foundation, and Society for Leukocyte Biology

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Lawrence H Brent, MD  Associate Professor of Medicine, Jefferson Medical College of Thomas Jefferson University; Chair, Program Director, Department of Medicine, Division of Rheumatology, Albert Einstein Medical Center

Lawrence H Brent, MD is a member of the following medical societies: American Association for the Advancement of Science, American Association of Immunologists, American College of Physicians, and American College of Rheumatology

Disclosure: Abbott Honoraria Speaking and teaching; Centocor Consulting fee Consulting; Genentech Grant/research funds Other; HGS/GSK Honoraria Speaking and teaching; Omnicare Consulting fee Consulting; Pfizer Honoraria Speaking and teaching; Roche Speaking and teaching; Savient Honoraria Speaking and teaching; UCB Honoraria Speaking and teaching

Alex J Mechaber, MD, FACP  Senior Associate Dean for Undergraduate Medical Education, Associate Professor of Medicine, University of Miami Miller School of Medicine

Alex J Mechaber, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, and Society of General Internal Medicine

Disclosure: Nothing to disclose.

Chief Editor

Herbert S Diamond, MD  Adjunct Professor of Medicine, Division of Rheumatology, University of Pittsburgh School of Medicine; Chairman Emeritus, Department of Internal Medicine, Western Pennsylvania Hospital

Herbert S Diamond, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American College of Rheumatology, American Medical Association, and Phi Beta Kappa

Disclosure: Merck Ownership interest Other; Smith Kline Ownership interest Other; Zimmer Ownership interest Other

References
  1. Stanton-Hicks M, Janig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. Oct 1995;63(1):127-33. [Medline].

  2. Kemler MA, van de Vusse AC, van den Berg-Loonen EM, et al. HLA-DQ1 associated with reflex sympathetic dystrophy. Neurology. Oct 12 1999;53(6):1350-1. [Medline].

  3. Sebastin SJ. Complex regional pain syndrome. Indian J Plast Surg. May 2011;44(2):298-307. [Medline]. [Full Text].

  4. Coderre TJ, Bennett GJ. A hypothesis for the cause of complex regional pain syndrome-type I (reflex sympathetic dystrophy): pain due to deep-tissue microvascular pathology. Pain Med. Aug 2010;11(8):1224-38. [Medline].

  5. Goebel A. Complex regional pain syndrome in adults. Rheumatology (Oxford). Oct 2011;50(10):1739-50. [Medline].

  6. Cimaz R, Matucci-Cerinic M, Zulian F, Falcini F. Reflex sympathetic dystrophy in children. J Child Neurol. Jun 1999;14(6):363-7. [Medline].

  7. Badri T, Ben Jennet S, Fenniche S, Benmously R, Mokhtar I, Hammami H. Reflex sympathetic dystrophy syndrome in a child. Acta Dermatovenerol Alp Panonica Adriat. Jun 2011;20(2):77-9. [Medline].

  8. van Hilten BJ, van de Beek WJ, Hoff JI, et al. Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med. Aug 31 2000;343(9):625-30. [Medline].

  9. Gobelet C, Waldburger M, Meier JL. The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy. Pain. Feb 1992;48(2):171-5. [Medline].

  10. Kemler MA, Barendse GA, Van Kleef M, et al. Electrical spinal cord stimulation in reflex sympathetic dystrophy: retrospective analysis of 23 patients. J Neurosurg. Jan 1999;90(1 Suppl):79-83. [Medline].

  11. Kemler MA, Barendse GA, van Kleef M, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med. Aug 31 2000;343(9):618-24. [Medline].

  12. Driessens M, Dijs H, Verheyen G, Blockx P. What is reflex sympathetic dystrophy?. Acta Orthop Belg. Jun 1999;65(2):202-17. [Medline].

  13. Johnson JP, Obasi C, Hahn MS, Glatleider P. Endoscopic thoracic sympathectomy. J Neurosurg. Jul 1999;91(1 Suppl):90-7. [Medline].

  14. Lundborg C, Dahm P, Nitescu P, et al. Clinical experience using intrathecal (IT) bupivacaine infusion in three patients with complex regional pain syndrome type I (CRPS-I). Acta Anaesthesiol Scand. Jul 1999;43(6):667-78. [Medline].

  15. Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy?. Ann Neurol. Jun 2009;65(6):629-38. [Medline].

  16. Oerlemans HM, Perez RS, Oostendorp RA, Goris RJ. Objective and subjective assessments of temperature differences between the hands in reflex sympathetic dystrophy. Clin Rehabil. Oct 1999;13(5):430-8. [Medline].

  17. Pandita D, Danielson BD, Potti A, et al. Complex regional pain syndrome type-1: a rare complication of arteriovenous graft placement. J Rheumatol. Oct 1999;26(10):2254-6. [Medline].

  18. Poncelet C, Perdu M, Levy-Weil F, et al. Reflex sympathetic dystrophy in pregnancy: nine cases and a review of the literature. Eur J Obstet Gynecol Reprod Biol. Sep 1999;86(1):55-63. [Medline].

  19. Reuben SS, Steinberg RB, Madabhushi L, Rosenthal E. Intravenous regional clonidine in the management of sympathetically maintained pain. Anesthesiology. Aug 1998;89(2):527-30. [Medline].

  20. Schwartzman RJ. New treatments for reflex sympathetic dystrophy. N Engl J Med. Aug 31 2000;343(9):654-6. [Medline].

  21. Schwartzman RJ, Maleki J. Postinjury neuropathic pain syndromes. Med Clin North Am. May 1999;83(3):597-626. [Medline].

  22. Severens JL, Oerlemans HM, Weegels AJ, et al. Cost-effectiveness analysis of adjuvant physical or occupational therapy for patients with reflex sympathetic dystrophy. Arch Phys Med Rehabil. Sep 1999;80(9):1038-43. [Medline].

  23. Viel E, Ripart J, Pelissier J, Eledjam JJ. Management of reflex sympathetic dystrophy. Ann Med Interne (Paris). Apr 1999;150(3):205-10. [Medline].

  24. Wesselmann U, Srinivasa NR. Reflex sympathetic dystrophy and causalgia. Anesth Clin North Am. 1997;15:407-27.

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.